IQVIA Holdings company profile
Company profile
IQVIA Holdings has 95,000 employees and is headquartered in Durham, United States.
Based in Durham, North Carolina, and in existence since 1982, IQVIA Holdings Inc. serves drug developers, biotechnology firms, device makers and consumer health companies with data, analytics and research services. Its activities include cloud-based software for commercial teams, real-world evidence studies, consulting on advanced analytics, clinical trial management, central laboratory and genomic testing, and contract sales with medical affairs support. Customers are located in the Americas, Europe, Africa and the Asia-Pacific region. A biosimilar development collaboration with Kexing Biopharm is also part of its work.
In the fiscal year ended December 2025, revenue reached 16.3 billion US dollars, up 5.9% on the previous year, and net income was 1.4 billion US dollars. The company employed 95,000 people. By region, the Americas generated 47.5% of revenue, EMEA 31.8% and Asia Pacific 20.7%. The company was previously named Quintiles IMS Holdings, Inc. until it changed its name in November 2017.
Company facts
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Headquarters
- 2400 Ellis Road, 27703, Durham
- Employees
- 95,000
- Chief executive
- Ari Bousbib
- Founded
- 1982
- Fiscal year
- January - December
- Listing
- IQV · NYSE
- Indices
- S&P 500
- Currency
- USD
- ISIN
- US46266C1053
- Website
- iqvia.com
IQVIA Holdings and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| IQVIA HoldingsIQV | United States | $40.51B | 95,000 | 13.9% | 29.9 |
| NateraNTRA | United States | $39.64B | 6,135 | -8.5% | — |
| Agilent TechnologiesA | United States | $48.04B | 18,200 | 24.5% | 33.6 |
| Mettler-Toledo InternationalMTD | United States | $33.15B | 16,600 | 27.8% | 36.2 |
| IDEXX LaboratoriesIDXX | United States | $53.28B | 11,000 | 32.5% | 45.6 |
| Labcorp HoldingsLH | United States | $29.81B | 71,000 | 11.2% | 30.1 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
